Please try another search
Jiangsu Gdk Biological Technology Co., Ltd engages in the scientific research, production, operation, and service of human vaccines. The company offers quadrivalent influenza virus split vaccines. Its product pipeline has coverage for the prevention of principal infectious diseases, including influenza, rabies, chickenpox, herpes zoster, and pneumonia. The company was founded in 2008 and is based in Taizhou, China.
Name | Age | Since | Title |
---|---|---|---|
Jun Yu | 53 | - | Chairman of the Board & GM |
Hua Cheng | 43 | - | Independent Director |
Dachang Wei | 54 | - | Chairman of the Supervisory Board |
Rong Shao | 61 | - | Independent Director |
Ling Huang | 56 | - | Supervisor |
Shenqian Nie | 74 | - | Director |
Huisheng Yu | 26 | - | Employee Supervisor |
Jianqiang Guan | 64 | - | Independent Director |
Liangbin Zhang | 47 | - | Director |
Jianguo Xia | 50 | - | Deputy GM & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review